911 results on '"He, Qing-Yu"'
Search Results
2. Two synonymous single-nucleotide polymorphisms promoting fluoroquinolone resistance of Escherichia coli in the environment
3. A multi-omics dataset of human transcriptome and proteome stable reference
4. Unveiling a novel mechanism for competitive advantage of ciprofloxacin-resistant bacteria in the environment through bacterial membrane vesicles
5. Protective effects of microalgal carotenoids against glycosylation-induced collagen degradation in skin
6. LAFEM: A Scoring Model to Evaluate Functional Landscape of Lysine Acetylome
7. Histone deacetylase inhibitor pracinostat suppresses colorectal cancer by inducing CDK5-Drp1 signaling-mediated peripheral mitofission
8. Polyphyllin D punctures hypertrophic lysosomes to reverse drug resistance of hepatocellular carcinoma by targeting acid sphingomyelinase
9. A five-protein prognostic signature with GBP2 functioning in immune cell infiltration of clear cell renal cell carcinoma
10. Identifying PE2 and PE5 Proteins from Existing Mass Spectrometry Data Using pFind
11. Pan-Cancer Proteomics Analysis Reveals Wiskott–Aldrich Syndrome Protein as a Potential Regulator of Programmed Death-Ligand 1
12. Highly bioactive iridium metal-complex alleviates spinal cord injury via ROS scavenging and inflammation reduction
13. Alteration of mitochondrial protein succinylation against cellular oxidative stress in cancer
14. DDX17 promotes the growth and metastasis of lung adenocarcinoma
15. Targeting ARF1-IQGAP1 interaction to suppress colorectal cancer metastasis and vemurafenib resistance
16. Repurposing cinacalcet suppresses multidrug-resistant Staphylococcus aureus by disruption of cell membrane and inhibits biofilm by targeting IcaR
17. PTPLAD1 Regulates PHB-Raf Interaction to Orchestrate Epithelial-Mesenchymal and Mitofusion-Fission Transitions in Colorectal Cancer
18. Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease
19. Proteomic investigation into the action mechanism of berberine against Streptococcus pyogenes
20. Structure-based discovery of neoandrographolide as a novel inhibitor of Rab5 to suppress cancer growth
21. Post-translational modifications of CDK5 and their biological roles in cancer
22. MEST promotes lung cancer invasion and metastasis by interacting with VCP to activate NF-κB signaling
23. Genome-wide identification of key regulatory lncRNAs in esophageal cancer metastasis
24. Understanding the proteome encoded by “non-coding RNAs”: new insights into human genome
25. Improved SILAC method for double labeling of bacterial proteome
26. Dirhodium (II) complex interferes with iron-transport system to exert antibacterial action against Streptococcus pneumoniae
27. A Interacting Model: How TRIM21 Orchestrates with Proteins in Intracellular Immunity.
28. The mechanism of iron-compensation for manganese deficiency of Streptococcus pneumoniae
29. Sequential targeting of YAP1 and p21 enhances the elimination of senescent cells induced by the BET inhibitor JQ1
30. Evolution and molecular mechanism of PitAs in iron transport of Streptococcus species
31. Comprehensive analysis of the lysine acetylome and its potential regulatory roles in the virulence of Streptococcus pneumoniae
32. Identification of miR-515-3p and its targets, vimentin and MMP3, as a key regulatory mechanism in esophageal cancer metastasis: functional and clinical significance
33. Advances in targeted therapy for esophageal cancer
34. Genome-wide CRISPR/Cas9 screening identifies a targetable MEST-PURA interaction in cancer metastasis
35. Crucial residue Trp158 of lipoprotein PiaA stabilizes the ferrichrome-PiaA complex in Streptococcus pneumoniae
36. Echinatin suppresses esophageal cancer tumor growth and invasion through inducing AKT/mTOR-dependent autophagy and apoptosis
37. Supplementary Data from Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3
38. Supplementary Table from Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3
39. Supplementary Figure from Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3
40. Data from Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3
41. Supplementary Table 1 from Id1-Induced IGF-II and Its Autocrine/Endocrine Promotion of Esophageal Cancer Progression and Chemoresistance—Implications for IGF-II and IGF-IR–Targeted Therapy
42. Supplementary Figure Legends, Figures 1 - 14 from Id1-Induced IGF-II and Its Autocrine/Endocrine Promotion of Esophageal Cancer Progression and Chemoresistance—Implications for IGF-II and IGF-IR–Targeted Therapy
43. Supplementary Materials and Methods from Id1-Induced IGF-II and Its Autocrine/Endocrine Promotion of Esophageal Cancer Progression and Chemoresistance—Implications for IGF-II and IGF-IR–Targeted Therapy
44. EFHD1 , a novel mitochondrial regulator of tumor metastasis in clear cell renal cell carcinoma
45. Targeting ARF1-IQGAP1 interaction to suppress colorectal cancer metastasis and vemurafenib resistance.
46. Residue Lys219 of CpxR is critical in the regulation of the antibiotic resistance of Escherichia coli.
47. Proteomic analysis on the antibacterial activity of a Ru(II) complex against Streptococcus pneumoniae
48. Potential Role of Lysine Acetylation in Antibiotic Resistance of Escherichia coli
49. ZSWIM1 Promotes the Proliferation and Metastasis of Lung Adenocarcinoma Cells through the STK38/MEKK2/ERK1/2 Axis
50. A stable reference human transcriptome and proteome as a standard for reproducible omics experiments
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.